- Report
- May 2025
- 50 Pages
Global
From €2453EUR$2,650USD£2,063GBP
Talniflumate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It is a synthetic derivative of the naturally occurring compound talinolol, and is used to reduce inflammation and pain. Talniflumate is available in both oral and topical forms, and is often used in combination with other drugs to treat more severe cases of immune disorders.
Talniflumate is a relatively new drug, and the market is still in its early stages. It is expected to grow in the coming years, as more people are diagnosed with immune disorders and the need for effective treatments increases. The drug is also being studied for potential use in other conditions, such as asthma and allergies.
Some of the companies in the Talniflumate market include Pfizer, Merck, Novartis, and Sanofi. These companies are actively researching and developing new treatments for immune disorders, and are expected to be major players in the Talniflumate market in the future. Show Less Read more